Biosyntia Competitors and Similar CompaniesClear all

Zealand Pharma's competitors and similar companies include Spexis and XL-protein.

	Zealand Pharma Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines.	Spexis Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.	XL-protein XL-protein is a company that develops and commercializes its proprietary PASylation technology to extend the plasma half-life of biopharmaceuticals.
Founding Date	Founding Date 1998	Founding Date 1996	Founding Date 2009
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech diabetes drug development	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering biotech drug development pharma
Locations	Locations Søborg, DK HQ Boston, US Marlborough, US	Locations Allschwil, CH HQ	Locations Freising, DE HQ
Employees	Employees 385	Employees 50	Employees 5
Financial
Revenue (est.)	Revenue (est.) kr9.2b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr816k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr9.3b (FY, 2025)	Gross profit CHF755k (FY, 2023)	Gross profit N/A
Net income	Net income kr6.5b (FY, 2025)	Net income (CHF19.6m) (FY, 2023)	Net income N/A

For sources of this data, please see the company profile

Allschwil, CH

Employees

Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.

Freising, DE

Employees

XL-protein is a company that develops and commercializes its proprietary PASylation technology to extend the plasma half-life of biopharmaceuticals.

Financial